The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignancies
- DOI
- 10.1002/hem3.70306
- Published
- 2026-03
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70306,
title = {The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignancies},
author = {Elise R. A. Pennings and Frederick W. Thielen and Florence Broussais and Julio Delgado and Ulrich Jaeger and Carmen Sanges and Yolanda Cabrerizo and Lutgart Roux‐Opstaele and Caroline Dreuillet and Eglys Gonzalez‐Marcano and Olga Millán and Barbara Huber and Solène Clavreul and Natacha Bolaños and Samantha Nier and Jana Mihályová and Roman Hájek and Michaela Horňáková and Robin Doeswijk and Catherine Thieblemont and Michael Hudecek and Carin A. Uyl‐de Groot and Marie José Kersten},
year = {2026},
journal = {HemaSphere},
doi = {10.1002/hem3.70306},
url = {https://doi.org/10.1002/hem3.70306}
}RIS
TY - JOUR TI - The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignancies AU - Elise R. A. Pennings AU - Frederick W. Thielen AU - Florence Broussais AU - Julio Delgado AU - Ulrich Jaeger AU - Carmen Sanges AU - Yolanda Cabrerizo AU - Lutgart Roux‐Opstaele AU - Caroline Dreuillet AU - Eglys Gonzalez‐Marcano AU - Olga Millán AU - Barbara Huber AU - Solène Clavreul AU - Natacha Bolaños AU - Samantha Nier AU - Jana Mihályová AU - Roman Hájek AU - Michaela Horňáková AU - Robin Doeswijk AU - Catherine Thieblemont AU - Michael Hudecek AU - Carin A. Uyl‐de Groot AU - Marie José Kersten PY - 2026 JO - HemaSphere DO - 10.1002/hem3.70306 UR - https://doi.org/10.1002/hem3.70306 ER -
APA
Pennings, E. R. A., Thielen, F. W., Broussais, F., Delgado, J., Jaeger, U., Sanges, C., Cabrerizo, Y., Roux‐Opstaele, L., Dreuillet, C., Gonzalez‐Marcano, E., Millán, O., Huber, B., Clavreul, S., Bolaños, N., Nier, S., Mihályová, J., Hájek, R., Horňáková, M., Doeswijk, R., Thieblemont, C., Hudecek, M., Groot, C. A. U., & Kersten, M. J. (2026). The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignancies. HemaSphere. https://doi.org/10.1002/hem3.70306
Source records
- crossref · retrieved 2026-09-27T11:19:41.045Z